Trexquant Investment’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67M | Sell |
327,421
-57,501
| -15% | -$995K | 0.06% | 483 |
|
|
2025
Q1 | $8.42M | Buy |
384,922
+181,914
| +90% | +$3.98M | 0.1% | 316 |
|
|
2024
Q4 | $6.48M | Buy |
+203,008
| New | +$6.48M | 0.08% | 423 |
|
|
2024
Q3 | – | Sell |
-149,160
| Closed | -$5.72M | – | 1514 |
|
|
2024
Q2 | $5.72M | Buy |
+149,160
| New | +$5.72M | 0.09% | 365 |
|
|
2023
Q3 | – | Sell |
-51,988
| Closed | -$4.74M | – | 1436 |
|
|
2023
Q2 | $4.74M | Buy |
+51,988
| New | +$4.74M | 0.12% | 223 |
|
|
2022
Q3 | – | Sell |
-9,750
| Closed | -$441K | – | 1339 |
|
|
2022
Q2 | $441K | Buy |
+9,750
| New | +$441K | 0.02% | 900 |
|
|
2021
Q3 | – | Sell |
-10,262
| Closed | -$649K | – | 1112 |
|
|
2021
Q2 | $649K | Buy |
10,262
+5,212
| +103% | +$330K | 0.05% | 405 |
|
|
2021
Q1 | $217K | Buy |
+5,050
| New | +$217K | 0.02% | 926 |
|
|
2020
Q3 | – | Sell |
-17,189
| Closed | -$561K | – | 1179 |
|
|
2020
Q2 | $561K | Buy |
17,189
+8,559
| +99% | +$279K | 0.04% | 634 |
|
|
2020
Q1 | $231K | Buy |
+8,630
| New | +$231K | 0.02% | 936 |
|